Pubblicazioni

Obesity, type 2 diabetes mellitus and cardiovascular disease risk. an uptodate in the management of polycystic ovary syndrome

2016 - EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY

Orio, Francesco; Muscogiuri, Giovanna; Nese, Cinar; Palomba, Stefano; Savastano, Silvia; Tafuri, Domenico; Colarieti, Giorgio; La Sala, Giovanbattista; Colao, Annamaria; Yildiz, Bulent O

Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome. From Bench to Bedside

2016 - CURRENT PHARMACEUTICAL DESIGN

Muscogiuri, Giovanna; Palomba, Stefano; LaganÃ , Antonio Simone; Orio, Francesco

Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome. a randomized controlled trial

2016 - CLINICAL ENDOCRINOLOGY

Orio, F; Muscogiuri, G; Giallauria, F; Savastano, S; Bottiglieri, P; Tafuri, D; Predotti, P; Colarieti, G; Colao, A; Palomba, S

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients

2016 - HAEMATOLOGICA

Castagnetti, F; Breccia, M; Gugliotta, G; Martino, B; D'Adda, M; Stagno, F; Carella, Am; Avanzini, P; Tiribelli, M; Trabacchi, E; Visani, G; Gobbi, M; Salvucci, M; Levato, L; Binotto, G; Capalbo, Sf; Bochicchio, Mt; Soverini, S; Cavo, M; Martinelli, G; Alimena, G; Pane, F; Saglio, G; Rosti, G; Baccarani, M

Incidence of Severe (<= 10g/dl) Chronic Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib and Role of Erythropoietin Therapy

2016 - BLOOD

Cesini, L; Carmosino, I; Campanelli, M; Breccia, M; De Luca, Ml; Colafigli, G; Molica, M; Massaro, F; Vozella, F; Diverio, D; Mancini, M; Alimena, G; Latagliata, R

Efficacy and Safety of Ruxolitinib in Elderly Patients (> 75 years) with Myelofibrosis

2016 - BLOOD

Latagliata, R; Di Veroli, A; Palumbo, Ga; Bonifacio, M; Andriani, A; Polverelli, N; Trawinska, M; Tiribelli, M; Anaclerico, B; Benevolo, G; Petriccione, L; Martino, B; Centra, A; D'Adda, M; Crugnola, M; Cavazzini, F; Bergamaschi, M; Tieghi, A; Ibatici, A; Bosi, C; Perricone, M; Montanaro, M; Cavo, M; Breccia, M; Vianelli, N; Palandri, F

Psychological well-being and social support in chronic myeloid leukemia patients receiving lifelong targeted therapies

2016 - SUPPORTIVE CARE IN CANCER

Efficace, F; Breccia, M; Cottone, F; Okumura, I; Doro, M; Riccardi, F; Rosti, G; Baccarani, M

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

2016 - LEUKEMIA

Steegmann, Jl; Baccarani, M; Breccia, M; Casado, Lf; Garcia-Gutierrez, V; Hochhaus, A; Kim, Dw; Kim, Td; Khoury, Hj; Le Coutre, P; Mayer, J; Milojkovic, D; Porkka, K; Rea, D; Rosti, G; Saussele, S; Hehlmann, R; Clark, Re

Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegaly

2016 - BRITISH JOURNAL OF HAEMATOLOGY

Palandri, F; Polverelli, N; Breccia, M; Nicolino, B; Vitolo, U; Alimena, G; Cavo, M; Vianelli, N; Benevolo, G

CHRONIC MYELOID LEUKEMIA WITH EXTREME THROMBOCYTOCIS AT THE DIAGNOSIS: A NEW SUBSET

2016 - HAEMATOLOGICA

Sora, F; Alessandra, I; Latagliata, R; Castagnetti, F; Fava, C; Annunziata, M; Gozzini, A; Montefusco, E; Avanzini, P; Pregno, P; Cerrano, M; Celesti, F; Galimberti, S; Bocchia, M; Breccia, M; Cattaneo, D; Rosti, G; Sica, S

Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis

2016 - SUPPORTIVE CARE IN CANCER

Breccia, M; Graffigna, G; Galimberti, S; Iurlo, A; Pungolino, E; Pizzuti, M; Maggi, A; Falzetti, F; Capalbo, Sf; Intermesoli, T; Maffioli, M; Elena, C; Melosi, A; Simonetti, F; Capochiani, E; Della Seta, R; Pacilli, M; Luppi, M; Di Renzo, N; Mastrullo, L; Trabacchi, E; Vallisa, D; Rapezzi, D; Orlandi, Em; Gambacorti-Passerini, C; Efficace, F; Alimena, G

DEFERASIROX IN THE TREATMENT OF IRON OVERLOAD DURING MYELOPROLIFERATIVE NEOPLASMS (MPN)

2016 - HAEMATOLOGICA

Porrini, R; De Muro, M; Trawinska, M; Di Veroli, A; Leonetti, Sc; Petriccione, L; Spadea, A; D'Addosio, A; Rago, A; Montanaro, M; Andriani, A; Niscola, P; Montefusco, E; Breccia, M; Alimena, G; Latagliata, R

The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia

2016 - ANNALS OF HEMATOLOGY

Efficace, F; Rosti, G; Breccia, M; Cottone, F; Giesinger, Jm; Stagno, F; Iurlo, A; Rossi, Ar; Luciano, L; Martino, B; Galimberti, S; Turri, D; Bergamaschi, M; Tiribelli, M; Fava, C; Angelucci, E; Mandelli, F; Baccarani, M

Young CML Patients Treated Frontline with Imatinib or Second Generation TKIs: Clinical Characteristics and Outcome

2016 - BLOOD

Annunziata, M; Latagliata, R; Iurlo, A; Breccia, M; Capodanno, I; Barate, C; Sora, F; Crisa, E; Anaclerico, B; Isidori, A; Sgherza, N; Gozzini, A; Russo, S; Avanzini, P; Musolino, C; Sica, S; Cedrone, M; Galimberti, S; Ferrero, D; Visani, G; Alimena, G; Ferrara, F; Rossi, Ar

Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Azacytidine Treatment

2016 - BLOOD

Latagliata, R; Niscola, P; Spiriti, Maa; Carmosino, I; Cesini, L; Sarlo, C; Piccioni, A; Campagna, A; De Luca, Ml; Vozella, F; Campanelli, M; Mancini, M; Breccia, M; Avvisati, G; Tafuri, A; de Fabritiis, P; Alimena, G; Girmenia, C

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome

2016 - ONCOTARGET

Iurlo, A; Nobili, A; Latagliata, R; Bucelli, C; Castagnetti, F; Breccia, M; Abruzzese, E; Cattaneo, D; Fava, C; Ferrero, D; Gozzini, A; Bonifacio, M; Tiribelli, M; Pregno, P; Stagno, F; Vigneri, P; Annunziata, M; Cavazzini, F; Binotto, G; Mansueto, G; Russo, S; Falzetti, F; Montefusco, E; Gugliotta, G; Storti, S; D'Addosio, Am; Scaffidi, L; Cortesi, L; Cedrone, M; Rossi, Ar; Avanzini, P; Mauro, E; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sora, F; Rege-Cambrin, G; Sica, S; Luciano, L; Galimberti, S; Orlandi, Em; Bocchia, M; Tettamanti, M; Alimena, G; Saglio, G; Rosti, G; Mannucci, Pm; Cortelezzi, A

Cutaneous Lesions Anticipating Accelerated Phase of Multidrug Resistant Chronic Myeloid Leukemia Responsive to Ponatinib

2016 - MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

Breccia, M; Colafigli, G; Quattrocchi, L; Abruzzese, E; Alimena, G

AZACITIDINE IN THE TREATMENT OF PH- MYELOPROLIFERATIVE NEOPLASMS IN BLASTIC PHASE: THE EXPERIENCE OF GRUPPO LAZIALE FOR THE STUDY OF PH- SMPC

2016 - HAEMATOLOGICA

Di Veroli, A; Anaclerico, B; Villiva, N; Niscola, P; Montanaro, M; Cimino, G; Voso, Mt; Trawinska, M; Andriani, A; Fianchi, L; Breccia, M; Latagliata, R

Adverse events associated with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia

2016 - EXPERT OPINION ON DRUG SAFETY

Breccia, M; Colafigli, G; Molica, M; Alimena, G

Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy

2016 - BLOOD

Bocchia, M; Aprile, L; Sirianni, S; Abruzzese, E; Gozzini, A; Castagnetti, F; Puccetti, L; Sora, F; Galimberti, S; Sicuranza, A; Tiribelli, M; Breccia, M; Iurlo, A; Bartalucci, G; Cattaneo, D; Mulas, O; Barate, C; Caocci, G; Sica, S; Rosti, G; Bosi, A; Raspadori, D

Frontline Dasatinib Treatment in a "Real-Life" Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia

2016 - NEOPLASIA

Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Guarini, A; Fava, C; Gozzini, A; Bonifacio, M; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Castagnetti, F; Capodanno, I; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Rizzo, M; Antolino, A; Mauro, E; Sgherza, N; Luciano, L; Tiribelli, M; Rossi, Ar; Trawinska, M; Vigneri, P; Breccia, M; Rosti, G; Alimena, G

Early molecular response in chronic myeloid leukemia and halving time: Latest evidences

2016 - LEUKEMIA RESEARCH

Breccia, M; Molica, M; Colafigli, G; Massaro, F; Alimena, G.

Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia

2016 - AMERICAN JOURNAL OF HEMATOLOGY

Gugliotta, G; Castagnetti, F; Breccia, M; Gozzini, A; Usala, E; Carella, Am; Rege-Cambrin, G; Martino, B; Abruzzese, E; Albano, F; Stagno, F; Luciano, L; D'Adda, M; Bocchia, M; Cavazzini, F; Tiribelli, M; Lunghi, M; Falcone, Ap; Musolino, C; Levato, L; Venturi, C; Soverini, S; Cavo, M; Alimena, G; Pane, F; Martinelli, G; Saglio, G; Rosti, G; Baccarani, M

Expanded Phase 1 Study of ABL001, a Potent, Allosteric Inhibitor of BCR-ABL, Reveals Significant and Durable Responses in Patients with CML-Chronic Phase with Failure of Prior TKI Therapy

2016 - BLOOD

Hughes, Tp; Goh, Yt; Ottmann, Og; Minami, H; Rea, D; Lang, F; Mauro, Mj; Deangelo, Dj; Talpaz, M; Hochhaus, A; Breccia, M; Cortes, Je; Heinrich, Mc; Janssen, J; Steegmann, Jl; Mahon, Fx; Duan, R; Iyer, V; Hynds, D; Vanasse, Gj; Kim, Dw

IS A 1ST LINE ERYTHROPOIETIN APPROACH IN MYELODYSPLASTIC PATIENTS WITH DEL 5Q-USEFUL?

2016 - HAEMATOLOGICA

Volpicelli, P; Mancini, M; Ferretti, A; Carmosino, I; De Luca, Ml; Vozella, F; Trasarti, S; Sangiorgi, E; Lisi, C; Breccia, M; Latagliata, R; Alimena, G